Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
Novo Nordisk
BA
bactrian
Community Contributor
A Quality Compounder Marked Down on Overblown Fears
Novo Nordisk , a global leader in diabetes and obesity treatments, is trading at a deep discount to both its historical multiples and intrinsic value. The ADR is now priced at $47.05 , reflecting a normalized P/E ratio of just 13.4× , down from a five-year average closer to 25–30×.
View narrative
US$120.72
FV
57.7% undervalued
intrinsic discount
15.71%
Revenue growth p.a.
Set Fair Value
26
users have liked this narrative
7
users have commented on this narrative
73
users have followed this narrative
New
narrative
ASML Holding
IN
Investingwilly
Community Contributor
Why Now is the Time to buy ASML
What Does ASML Do? ASML Holding N.V. is a Dutch company and the world’s only supplier of extreme ultraviolet (EUV) lithography machines —a critical technology used to produce the world’s most advanced computer chips.
View narrative
US$1.00k
FV
28.0% undervalued
intrinsic discount
15.17%
Revenue growth p.a.
Set Fair Value
35
users have liked this narrative
6
users have commented on this narrative
96
users have followed this narrative
Updated
narrative
Wyndham Hotels & Resorts
ZW
Zwfis
Community Contributor
Wyndham Continues Global Expansion with 19% Ancillary Revenue Growth
WH is a company that I actually took interest in a couple of months ago when I happened to stay at one of their franchise hotels. I had to leave early in the morning at like 4 and when I went out to the parking lot I was astounded that in the little town I was was absolutely full.
View narrative
US$105.80
FV
20.6% undervalued
intrinsic discount
13.23%
Revenue growth p.a.
Set Fair Value
7
users have liked this narrative
2
users have commented on this narrative
15
users have followed this narrative
New
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Meritage Homes
AN
AnalystLowTarget
Consensus Narrative from 8 Analysts
Rising Costs And Demographic Shifts Will Bleed US Housing Value
Key Takeaways Persistent housing affordability issues and unfavorable demographic shifts are reducing demand for Meritage's core entry-level homes and limiting future growth opportunities. Elevated costs, geographic overexposure, and evolving consumer preferences are compressing margins and increasing risks to long-term profitability and market stability.
View narrative
US$60.00
FV
20.3% overvalued
intrinsic discount
4.50%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
1 day ago
author updated this narrative
Louisiana-Pacific
AN
AnalystLowTarget
Consensus Narrative from 10 Analysts
Declining US Housing And Regulatory Hurdles Will Undermine Value
Key Takeaways Overreliance on North American demand and traditional wood products makes revenue and margins vulnerable to regional downturns, regulatory shifts, and sustainable material adoption. Climate risks and stricter environmental regulations raise costs and create volatility in operations, threatening long-term profitability and market stability.
View narrative
US$71.00
FV
27.9% overvalued
intrinsic discount
4.01%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
1 day ago
author updated this narrative
Planet Fitness
AN
AnalystLowTarget
Consensus Narrative from 16 Analysts
US Fitness Oversaturation And Online Churn Will Erode Profitability
Key Takeaways Shifting consumer preferences toward boutique fitness, at-home options, and digital platforms threaten Planet Fitness's member growth and revenue stability. Intensifying competition, market saturation, and easier membership cancellation are eroding brand differentiation, compressing margins, and boosting customer churn.
View narrative
US$105.00
FV
1.6% overvalued
intrinsic discount
11.54%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
1 day ago
author updated this narrative
Cognex
AN
AnalystLowTarget
Consensus Narrative from 18 Analysts
Global Slowdown And Pricing Battles Will Dampen Machine Vision Prospects
Key Takeaways Deglobalization, trade tensions, and reliance on cyclical markets are driving revenue volatility and shrinking Cognex's growth opportunities. Rising competition, price pressures, and industry commoditization threaten Cognex's margins, pricing power, and long-term earnings stability.
View narrative
US$31.00
FV
32.0% overvalued
intrinsic discount
7.46%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
1 day ago
author updated this narrative
Gentex
AN
AnalystLowTarget
Consensus Narrative from 9 Analysts
EV Transition And China Trade Barriers Will Cripple Legacy Revenues
Key Takeaways Rapid automotive tech shifts and OEM vertical integration threaten Gentex's core products, revenue streams, and margin stability. Intensifying competition, decontenting trends, and rising trade barriers limit growth and erode earnings power, especially in key global markets.
View narrative
US$24.00
FV
10.9% overvalued
intrinsic discount
5.62%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
1 day ago
author updated this narrative
Jazz Pharmaceuticals
AN
AnalystLowTarget
Consensus Narrative from 17 Analysts
Patent Expirations And Generics Will Erode Revenues Yet Spark Hope
Key Takeaways Revenue and margins face threats from upcoming patent expirations, generic competition, and global pricing pressures, especially in the sleep and rare disease franchises. Heavy dependence on acquisitions and global rollout exposes Jazz to integration, financial leverage, and payer-driven pricing risks that may constrain long-term earnings growth.
View narrative
US$145.00
FV
23.2% undervalued
intrinsic discount
4.06%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
1 day ago
author updated this narrative
RLI
AN
AnalystLowTarget
Consensus Narrative from 3 Analysts
Climate Catastrophes And Tech Shifts Will Undermine Valuation
Key Takeaways Rising climate risks and shifting technology trends threaten margins, increase volatility, and undermine demand for traditional insurance offerings in RLI's core segments. Intensifying competition, escalating costs, and over-reliance on niche U.S. markets weaken profitability and expose RLI to concentrated regulatory and economic shocks.
View narrative
US$59.00
FV
12.8% overvalued
intrinsic discount
1.25%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
1 day ago
author updated this narrative
Matador Resources
AN
AnalystLowTarget
Consensus Narrative from 18 Analysts
Accelerating Renewables Will Strand Permian Basin Assets
Key Takeaways The rise of renewables, emissions regulations, and alternative technologies threatens Matador's core oil and gas business, pressuring revenue and shrinking its addressable market. Increasing capital demands for production and infrastructure heighten volatility, strain the balance sheet, and put future earnings growth and returns at risk.
View narrative
US$49.00
FV
5.0% undervalued
intrinsic discount
3.74%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
1 day ago
author updated this narrative
NOV
AN
AnalystLowTarget
Consensus Narrative from 21 Analysts
Decarbonization Will Crush Oilfield Order Volumes
Key Takeaways Heavy reliance on traditional oil and gas exposes NOV to declining demand, revenue instability, and intensified competition amid industry transition and consolidation. Failure to diversify leaves NOV vulnerable to technological disruption, increasing ESG pressures, and rising capital costs, threatening profitability and long-term viability.
View narrative
US$11.55
FV
3.0% overvalued
intrinsic discount
-2.96%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
1 day ago
author updated this narrative
Value any company in seconds
Popular companies